SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Wednesday reported a loss of $2.7 million in its fourth quarter.
The San Diego-based company said it had a loss of 8 cents per share.
The biotechnology company posted revenue of $526,000 in the period.
For the year, the company reported that its loss narrowed to $11.4 million, or 34 cents per share. Revenue was reported as $21.7 million.
In the final minutes of trading on Wednesday, the company's shares hit 34 cents. A year ago, they were trading at $2.10.